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indicating that all TORCs were subject to active nuclear
export.
A microscopy-based screen was developed to iden-
tify genes that induce nuclear accumulation of TORC1-
eGFP. HeLa cells were cotransfectedwith TORC1-eGFP
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250 Massachusetts Avenue in combination with approximately 7680 individual full-
length cDNA constructs [8], and the relative amounts ofCambridge, MA 02139
eGFP fluorescence in the cytoplasm and the nucleus
were determined with an automated imaging system
(Figure 1I). Translocation induced by LMBwas detectedSummary
in virtually all control wells. We utilized confocal micros-
copy to confirm TORC1-eGFP translocation in the high-The CREB family of proteins are critical mediators of
est scoring hits. Althoughmost of the potential hits fromgene expression in response to extracellular signals
this screen represented dying, rounded cells, twoand are essential regulators of adaptive behavior and
cDNAs encoding the murine transient receptor potentiallong-termmemory formation [1–4]. The TORCproteins
cation channel, subfamily V, member 6 (TRPV6) and awere recently described as potent CREB coactivators,
murine cyclic AMP (cAMP)-dependent protein kinase Abut their role in regulation of CREB activity remained
catalytic subunit (cAMP-dependent protein kinaseunknown [5, 6]. TORC proteins were found to be ex-
[PKA]) reproducibly resulted in TORC1-eGFP transloca-ported from thenucleus in aCRM1-dependent fashion.
tion. HeLa cells stably expressing TORC1-eGFP (HeLa::A high-throughput microscopy-based screen was de-
TORC1-eGFP cells) were transfected with either theveloped to identify genes and pathways capable of
TRPV6 or PKA cDNAs along with an alkaline phospha-inducing nuclear TORC accumulation. Expression of
tase expression plasmid to mark transfected cells, andthe catalytic subunit of PKA and the calcium channel
they were evaluated by confocal microscopy. BothTRPV6 relocalized TORC1 to the nucleus. Nuclear ac-
TRPV6 and PKA resulted in virtually all the TORC1-eGFPcumulation of the three human TORC proteins was
moving to the nucleus in transfected cells (Figuresinduced by increasing intracellular cAMP or calcium
1J–1L).levels. TORC1 and TORC2 translocation in response
to calcium, but not cAMP, was mediated by cal-
cineurin, andTORC1was shown to bedirectly dephos-
TORC Translocation Is Regulated by cAMPphorylated by calcineurin. TORC function was shown
Translocation induced by PKA suggests that TORC lo-to be essential for CRE-mediated gene expression in-
calization would be regulated by cAMP levels. Indeed,duced by cAMP, calcium, or GPCR activation, and nu-
TORC1-eGFP was efficiently shuttled to the nucleusclear transport of TORC1 was sufficient to activate
after treatment of HeLa cells with either a combinationCRE-dependent transcription. Drosophila TORC was
of forskolin (an adenyl cyclase agonist) and 3-isobutyl-also shown to translocate in response to calcineurin
1-methylxanthine (IBMX; a phosphodiesterase inhibitor)activation in vivo. Thus, TORC nuclear translocation
or dibutyryl-cAMP (db-cAMP) alone (Figures 2A–2C).is an essential, conserved step in activation of cAMP-
Similarly, TORC2-eGFP and TORC3-eGFP translocatedresponsive genes.
to the nucleus in response to forskolin in stably express-
ing HEK293 cells (Figures 2D, 2E, 2G, and 2H), and both
Results and Discussion TORC2-eGFP and TORC3-eGFP accumulated in the nu-
cleus in cells transfected with PKA (data not shown).
Identification of Genes that Affect Localization in the HEK293::TORC-eGFP cell lines was
TORC Localization examined in response to isoproterenol, a 2-adrenergic
Although transducers of regulated CREB (TORCs) are receptor agonist, to determine if TORCs also respond
transcriptional coactivators, both an amino-terminal to signaling through endogenousGs-coupled receptors.
FLAG-TORC1 fusion protein as well as a carboxy-termi- Both TORC2-eGFP and TORC3-eGFP rapidly accumu-
nal TORC1-eGFP fusion protein were present predomi- lated in the nucleus after exposure to isoproterenol (Fig-
nantly in the cytoplasm of transfected HeLa cells (Fig- ures 2F and 2I). The localization of endogenous TORC2
ures 1A and 1C). Whereas TORC2- and TORC3-eGFP was examined in HEK293 cells by immunohistochemical
fusions were constitutively present in the nucleus in staining after forskolin exposure to confirm that endoge-
HeLa cells (see Figure S1, available with this paper’s nous TORCs translocate in response to cAMP. Un-
Supplemental Data online), they were cytoplasmic in treated cells displayed diffuse TORC2 staining through-
HEK293 cells (Figures 1E and 1G). All of the human out the cell with little clear nuclear staining (compare
TORCs accumulated in the nucleus after treatment with 2J and 2L, stained with Hoechst). In contrast, cells ex-
leptomycin B (LMB), an inhibitor of CRM1-mediated nu- posed to forskolin displayed predominantly nuclear
clear export of proteins [7] (Figures 1B, 1D, 1F, and 1H), TORC2 staining indistinguishable from that seen when
the nuclei were stained with Hoechst (Figures 2K and
2M). In contrast to HeLa cells, the nuclear import of*Correspondence: mark.labow@pharma.novartis.com
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Figure 1. TORC Proteins Are Regulated by
Subcellular Compartmentalization
HeLa cells were transfected with FLAG-
TORC1 (A and B) or TORC1-eGFP (C and D).
HEK293 cells were transfected with TORC2-
eGFP (E and F) or TORC3-eGFP (G and H).
Cells were either untreated or treated with
LMB for 90 min. FLAG-tagged protein was
visualized by immunofluorescence, and eGFP-
tagged proteins were directly visualized by
fluorescence in all experiments. The ratio of
nuclear/cytoplasmic fluorescence of TORC1-
eGFP after cotransfection with 7680 individ-
ual cDNAs is shown (I). Data for control wells
treated with LMB are shown as X’s, and those
containing TRPV6 and PKA are indicated.
Confocal localization of TORC1-eGFP trans-
fected with empty vector (J), TRPV6 (K), or
PKA (L) expression plasmids is shown. Alka-
line phosphatase staining (pink) marks trans-
fected cells, with Hoechst nuclear DNA stain-
ing in blue and TORC1-eGFP in green.
TORC1-eGFP was slow in HEK293 cells and required mulation of TORC1-eGFP (Figure 3E). The effect of CsA
on TRPV6-induced translocation was also examined.both LMBand forskolin/IBMXor isoproterenol treatment
(Figure S3; data not shown), suggesting the need for Expression of TRPV6 efficiently induced nuclear translo-
cation of TORC1-eGFP (Figures 3F and 3G). Treatmentboth an import signal and blockade of export in this cell
line to observe the majority of TORC1 to accumulate in of TRPV6-overexpressing cells withCsA for 1 hr resulted
in nearly complete transport of TORC1-eGFP back tothe nucleus.
the cytoplasm (Figure 3H), confirming that TORC trans-
location was specifically due to calcineurin activationTORC Translocation Is Regulated by Calcineurin
and not due to other potentially toxic side-effects ofTRPV6 is a calcium channel that is suspected to be a
TRPV6 overexpression.store-operated channel involved in capacitative calcium
It should be noted that transfection with an activeentry (CCE), which can induce calcium entry current
calcineurin construct induced nuclear translocation ofwhen overexpressed [9]. CCE induces nuclear translo-
TORC2-eGFP but not TORC3-eGFP in HEK293 cells, yetcation of nuclear factor of activated T cells (NF-AT)
nuclear translocation of all three human TORC-eGFPthrough dephosphorylation of NF-AT by the calcium-
proteins in HEK293 cells was facilitated by ionomycin.dependent phosphatase calcineurin [10]. The localiza-
Further, the ionomycin-induced translocation of TORC1-tion of TORC1 was examined in response to ionomycin,
eGFPwas completely blocked byCsA, whereas TORC2-a calcium ionophore, or cyclopiazonic acid (CPA), an
eGFPwas partially inhibited (Figure S3). The insensitivityinhibitor of the sarcoplasmic-endoplasmic reticulum
of translocation to CsA by TORC2 and TORC3 may indi-calcium ATPase, to determine if TORCs were regulated
cate that there are multiple calcium-induced events thatin a manner similar to NF-AT. Both agents induce ele-
can lead to translocation and that calcineurin activationvated intracellular calcium levels, and both potently in-
is sufficient, but not necessary, for TORC2 translocationduced nuclear accumulation of TORC1-eGFP (Figures
in response to calcium in HEK293 cells.3A–3B; Figures S2A–S2C). Translocation in response to
The effect of TRPV6 on expression of a calcineurin-ionomycin was blocked by the immunophillin binding
dependent NF-AT-driven reporter gene was examinedcalcineurin inhibitors CsA and FK506 (Figures 3C and
to confirm that TRPV6 was indeed an activator of cal-3D) but not by rapamycin, an immunophillin binding
cineurin. TRPV6 transfection potently induced an NF-compound that does not inhibit calcineurin (Figures
AT-dependent luciferase reporter gene in a CsA-sensi-S2D–S2F). Expression of a constitutively active cal-
cineurin mutant was sufficient to induce nuclear accu- tivemanner (Figure 3I). These results indicate that TORC
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studies because of the low abundance of endogenous
TORC proteins and the complication of multiple size
species of endogenous TORC1 proteins, possibly due to
alternative splicing (see below). Coexpression of active
calcineurin with FLAG-TORC1 in HeLa cells increases
the electrophoretic mobility of FLAG-TORC1, and this
mobility shift is blocked by exposure to CsA (Figure 3P),
demonstrating that either active calcineurin itself or a
protein activated by calcineurin modifies TORC1 in vivo.
These observed mobility shifts were consistent with a
calcineurin-dependent dephosphorylation of FLAG-
TORC1. FLAG-TORC1 protein was purified from trans-
fected cells and treated with alkaline phosphatase or
purified calcineurin to determine if FLAG-TORC1 is di-
rectly dephosphorylated by calcineurin. Both calcineurin
and alkaline phosphatase treatment increased the elec-
trophoretic mobility of FLAG-TORC1, and both alkaline
phosphatase and calcineurin significantly decreased re-
activity of the FLAG-TORC1 protein with a phosphoser-
ine-specific antibody (Figure 3Q), demonstrating that
TORC1 is a phosphoprotein that is directly dephosphor-
ylated by calcineurin in vitro.
The subcellular localization of the single ancestral
Drosophila TORC (dTORC) was examined to determine
whether regulated nuclear translocation is a general
property of TORC proteins. An inducible eGFP-dTORC
transgene was constructed and stably integrated into
the Drosophila genome. Examination of intact salivary
Figure 2. TORCs Translocate in Response to Elevated cAMP Levels tissue from transgenic larvae demonstrated that dTORC
was predominantly present in the cytoplasm in un-HeLa cells stably expressing TORC1-eGFP were exposed to either
no treatment (A), forskolin and IBMX (B), or db-cAMP (C) for 2 hr. treated cells and rapidly translocated to the nucleus
HEK293 cells stably expressing TORC2-eGFP (D–F) or TORC3-eGFP upon ionomycin exposure (Figures 3R and 3S), with the
(G–I) were either untreated (D and G), treated with forskolin for 1 hr majority of the dTORC shuttling to the nucleus 10 min
(E and H), or treated with isoproterenol for 1 hr (F and I). Endogenous
after ionomycin exposure (see Movie 1). CotreatmentTORC2 was visualized in HEK293 cells that were either treated with
with CsA completely blocked dTORC translocation inthe vehicle DMSO (J and L) or with forskolin for 90 min (K and M).
response to ionomycin (Figure 3T), indicating that partic-Anti-TORC2 staining is shown (J and K) with the corresponding
Hoechst nuclear staining (L and M). ipation of calcineurin in the calcium-mediated cAMP
response element binding protein (CREB) response is
conserved between vertebrates and insects.
translocation is likely to occur concomitantly with that
of NF-AT and that TORC translocation may be a novel
target of the immunophillin binding immunosuppres- TORC Translocation Is Necessary and Sufficient
for CRE Activationsants. Additionally, this is the first demonstration that
TRPV6 expression is sufficient to activate calcineurin Induction of a cAMP response element (CRE)-depen-
dent luciferase reporter (CRE-luc) was compared in na-and ultimately NF-AT activity.
The role of calcineurin on nuclear transport of TORC1 ive HeLa cells and HeLa cells stably expressing a
TORC1-eGFP transgene to assess the affect of TORC1induced by other stimuli was also examined. CsA did
not block nuclear accumulation of any of the TORCs in localization on gene expression. Western blot analysis
indicated that HeLa::TORC1-eGFP cells expressed sig-response to increased intracellular cAMP levels induced
by forskolin (Figures 3J and 3K; data not shown). TORC nificantlymore TORC1 than naive cells (data not shown).
Untreated naive HeLa cells and HeLa::TORC1-eGFPtranslocation was also induced by either ultraviolet (UV)
irradiation of cells or the protein kinase C agonist phor- cells displayed similar levels of CRE-driven luciferase,
whereas LMB treatment resulted in a significant induc-bol 12-myristate-13-acetate (PMA) (Figures 3L–3O), and
translocation by these stimuli was blocked by CsA treat- tion only in the HeLa::TORC1-eGFP cells (Figure 4A).
This observation indicates that nuclear accumulation ofment, demonstrating a requirement for calcineurin in
these pathways. Thus, at least two independent path- TORC1-eGFP in the nucleus was sufficient to activate
CRE-driven gene expression. In addition, while iono-ways regulate TORC nuclear translocation: a calcineurin-
dependent pathway and a cAMP-dependent calcineurin- mycin and PMA resulted in a modest level of activation
in HeLa cells, these agents showed more than 10-foldindependent pathway.
FLAG-TORC1 protein was examined for calcineurin- larger increases in CRE-luciferase induction in HeLa::
TORC1-eGFP cells. Induction by ionomycin was com-dependent post-translational modification to determine
if TORC proteins were directly or indirectly modified pletely blocked by CsA. Thus, overexpression of TORC1
potently enhanced activation of CRE-driven gene ex-by calcineurin. The FLAG-TORC1 was used for these
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Figure 3. TORC1 Translocates in Response
to Elevated Calcium Levels through Cal-
cineurin Activation
HeLa cells stably expressing TORC1-eGFP
were exposed to either DMSO (A) or iono-
mycin (B–D) for 1 hr. Exposure to FK506 (C)
orCsA (D) for 1 hr completely blocked translo-
cation in response to ionomycin. HeLa cells
stably expressing TORC1-eGFP transiently
transfected with a plasmid expressing a con-
stitutively active form of calcineurin (E).
HeLa::TORC1-eGFP cells were transduced
with either the stop codon control virus (F) or
a virus expressing TRPV6 (G and H) and were
either untreated (F and G) or treated with CsA
for 1 hr (H). HEK293 cells were transiently
transfected with either empty vector or TRPV6
expression vector in combination with an NF-
AT-dependent luciferase reporter in the pres-
ence or absence of CsA (I). Luciferase values
are normalized to a cotransfected reporter to
control for transfection efficiency in all experi-
ments. HeLa::TORC1-eGFP cells were treated
with forskolin/IBMX (J), forskolin/IBMX in
combination with CsA (K), or PMA (L and M)
or were exposed to 254 nM UV light (N and
O). CsA blocked translocation by both PMA
and UV (M andO). HeLa cells transfected with
FLAG-TORC1 in combination with either the
empty vector control or active calcineurin and
were either untreated or treated with CsA,
and the mobility of FLAG-TORC1 was exam-
ined by Western analysis of whole cell lysate
(P). Purified FLAG-TORC1 protein was incu-
bated in the presence or absence of either
calf intestinal alkaline phosphatase (CIP) or
calcineurin (CnA) before Western analysis (Q)
with either anti-FLAG antibodies or antiphos-
phoserine antibodies. Salivary-gland tissue
expressing dTORC-eGFP from Drosophila
larvae was exposed to either the vehicle
DMSO (R), 5 M ionomycin (S), or 5 M iono-
mycin with 10 M CsA (T) for 1 hr.
pression in a calcineurin-dependent fashion. These ob- little effect on induction of an NF-AT-dependent lucifer-
ase reporter by ionomycin and PMA. It is important toservations suggest that the reported ability of CsA and
FK506 to block induction of a subset of CREB-respon- note that NF-AT is also activated by calcium in a cal-
cineurin-dependent fashion; thus, the effect of TORCsive genes in response to cAMPandmembrane depolar-
ization [11] is likely due to blockade of TORC function blockade is highly specific and downstream of cal-
cineurin. The siRNAs were shown to block TORC1 andby these agents. Since the effect of LMB is significantly
less than that observed with ionomycin, which also in- TORC2protein production byWestern blot analysis (Fig-
ure 4C). Decreased levels of TORC1andTORC2proteinsduces nuclear accumulation, it is likely that other signals
or modifications are required in combination with nu- had no effect on CREB1 phosphorylation by either stim-
ulus, consistent with previous observations that TORCsclear localization to achieve maximal transcriptional ac-
tivation. activate CRE-driven expression independently of CREB
phosphorlyation [6]. Although a single endogenousExpression of both TORC1 and TORC2 was de-
creased by siRNAs in HeLa cells to determine if TORCs TORC2 species was observed in HeLa cells, at least
two distinguishable isoforms of endogenous TORC1 areare essential for activation of CRE-dependent transcrip-
tion. In contrast to HEK293 cells, which were reported detected by Western analysis. These multiple TORC1
bands were not due to cross-reactivity of the antibodiesto predominantly express only TORC2 [6], HeLa cells
express comparable levels of both TORC1 and TORC2 to TORC2 or TORC3 because these isoforms were de-
tected with multiple antibodies that recognize distinctmRNA and protein (data not shown; see below). Knock-
down of either TORC1 or TORC2 alone was sufficient epitopes of TORC1, and the abundance of these pro-
teins was decreased specifically with TORC1 siRNAto modestly decrease CRE activation by forskolin/IBMX
or ionomycin/PMA in HeLa cells (Figure 4B). In contrast, (data not shown).
The siRNA data above is complicated by the needsimultaneous blockade with TORC1 and TORC2 siRNAs
strongly blocked induction by either stimulus. These to use multiple siRNAs and block multiple functionally
redundant TORC proteins. A dominant-interfering TORCeffects were specific because the TORC siRNAs had
Current Biology
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TORC proteins (data not shown). Expression of the T1-
44eGFP fusion protein potently blocked CRE activation
through either forskolin/IBMX or ionomycin/PMA but
had no effect on activation of an NF-AT reporter by
ionomycin/PMA (Figure 4D). Additionally, expression of
T1-44eGFP prevented CRE activation through a trans-
fected 2-adrenergic receptor by isoproterenol (Figure
4E). Thus, TORC function is both sufficient and essential
for CRE-driven gene expression induced by cAMP, cal-
cium agonists, and activation of Gs-coupled GPCRs.
Conclusions
Thedata presented in this paper demonstrate that TORC
translocation is a second, essential switch required for
activation of CRE-mediated gene expression by many,
if not all, inducers of CREB. CREB activation by cAMP
appears to require simultaneous nuclear translocation
of both PKA and TORC proteins. This observation pro-
vides a novel model that explains the rapid and efficient
activation of gene expression by cAMP. Previous stud-
ies have strongly implicated calcium-mediated CREB
activation in behavior, and yet calcium-mediated CREB
phosphorylation was shown in some instances to be
insufficient for transcriptional activation [12]. Nuclear
translocation of TORC in response to elevated calcium
levels provides a mechanism to explain these observa-
tions.
Translocation of the TORCs resembles that of NF-AT
in several ways. Both protein families are subject to
nuclear export and regulated nuclear import, and these
processes are directly regulated by calcineurin. It is in-
teresting to note that NF-AT has been shown to bind
and be regulated by the phosphoprotein binding protein
14-3-3 [13], and a recent study demonstrated that
TORC1 and TORC3 copurify with 14-3-3 from HEK293
cells [14], suggesting that these proteins may share ad-
ditional regulatory mechanisms. Additionally, the con-
servation of calcineurin-dependent translocation in hu-
Figure 4. TORC Nuclear Translocation Is Necessary and Sufficient
man andDrosophila TORC proteins further suggests thefor CRE Activation
importance of calcineurin in regulating CRE-dependent
HeLa cells and HeLa cells stably expressing TORC1-eGFP were
gene activation. Finally, because TORC1 translocationtransfected with CRE-luc and stimulated with LMB, CsA, ionomycin,
was shown to be sufficient to activate CREB-mediatedPMA, or the indicated combinations (A). HeLa cells were transiently
transfected with either a CRE or NF-AT luciferase plasmid before transcription, and activation of CREB has been sug-
transfection with siRNA versus GFP, TORC1 (T1), TORC2 (T2), or a gested to be a viable approach to enhancing memory
combination of both TORC1 and TORC2 (T1/T2), and they were and may be neuroprotective [15], the discovery of novel
treated with either DMSO, forskolin and IBMX, or ionomycin with compounds that induce TORC nuclear translocation
PMA (B). HeLa cells were transfected with either GFP or both
may provide new therapeutic agents for use as neuro-TORC1- and TORC2-specific siRNAs before induction with DMSO,
protective agents or memory enhancers.ionomycin, or forskolin and IBMX for 20 min and then underwent
lysis and Western blot analysis with antibodies specific for the indi-
Supplemental Datacated proteins (C). TORC1-specific antibodies detect at least two
Detailed Experimental Procedures, as well as several supplementaldistinct TORC1 species, indicated by arrows. HeLa cells were trans-
figures and a movie, are available online at http://www.current-fected with either the eGFP control or TORC1-44-eGFP expression
biology.com/cgi/content/full/14/24/2156/DC1/.vectors with either CRE luciferase or NF-AT luciferase before stimu-
lation with forskolin and IBMX or ionomycin and PMA (D). HEK293
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